Want to see IN:PAR full AI Analyst Report?
Par Drugs and Chemicals Limited (PAR) Income Statement
Par Drugs and Chemicals Limited Income Statement
Last quarter (Q1 2027), Par Drugs and Chemicals Limited's total revenue was $312.81M, an increase of 20.10% from the same quarter last year. In Q1, Par Drugs and Chemicals Limited's net income was $47.13M. See Par Drugs and Chemicals Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 1.04B | $ 1.01B | $ 956.40M | $ 950.95M | $ 746.15M | |
| $ 504.71M | $ 617.86M | $ 609.88M | $ 286.90M | $ 173.68M | |
| $ 370.43M | $ 171.02M | $ 81.62M | $ 141.38M | $ 46.98M | |
| Depreciation and Amortization | $ 37.03M | $ 36.47M | $ 34.36M | $ 32.33M | $ 32.81M |
| $ 211.32M | $ 195.01M | $ 229.53M | $ 184.46M | $ 163.61M | |
| $ 134.28M | $ 160.25M | $ 201.63M | $ 145.57M | $ 126.55M | |
| $ 38.73M | $ 18.98M | $ -356.42M | $ 5.22M | $ 479.00K | |
| $ 173.02M | $ 179.23M | $ 195.17M | $ 150.79M | $ 127.03M | |
| $ 131.09M | $ 133.58M | $ 145.01M | $ 113.34M | $ 92.13M | |
| Per Share Metrics | |||||
| Basic EPS | $ 10.65 | $ 10.86 | $ 11.78 | $ 9.21 | $ 7.49 |
| Diluted EPS | $ 10.65 | $ 10.86 | $ 11.78 | $ 9.21 | $ 7.49 |
| Weighted Average Shares Outstanding | 12.31M | 12.30M | 12.30M | 12.30M | 12.30M |
| Weighted Average Shares Outstanding (Diluted) | 12.31M | 12.30M | 12.30M | 12.30M | 12.30M |
Currency in INR